In this issue:
- Ethnic differences in NZ’s cancer rates among diabetics
- Cost-effectiveness of medical therapy and bariatric surgery according to diabetes severity
- Lifetime CV-renal disease risk in type 2 diabetes
- Personalised diets in newly diagnosed type 2 diabetes
- Impact of free fruit and vegetables in schools
- Weight loss and macronutrient specific response in overweight/obesity without metabolic disease
- Two papers on the modifying risk of HbA1c in COVID-19
- Factors affecting diabetes prevention programme attendance in deprived areas
- Primary prevention of CV and HF events with SGLT-2 inhibitors/GLP-1 agonists
- Effects of GLP-1 agonists on CV and renal outcomes
Please login below to download this issue (PDF)